This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event
In-Person: October 11-13 • Virtual: October 18-20Hyatt Regency • New Brunswick, NJ

David Tawes
Regional Inspector General, Department of Health and Human Services at OIG

Profile

Dave Tawes is a Regional Inspector General in the Office of Evaluation and Inspections, a component within the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services (HHS).  OEI conducts national evaluations that focus on the prevention of fraud, waste, and abuse in programs administered by HHS.  Mr. Tawes joined OEI as analyst in 1997 and has since contributed to more than 75 studies involving prescription drug issues, including Part B payment reforms, the Medicaid drug rebate program, the 340B drug discount program, and the availability of drugs to treat opioid addiction.  He also plays a key role in OEI’s workplanning efforts for future prescription drug studies.

Agenda Sessions

  • OIG Updates: Audits and Case Studies from the Manufacturer Perspective

    12:00pm